Loading…
Lower Prices Reduced with Increased Competition and Efficient Development of Drugs Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,722 other S bills in the 110th — cohort avg 42d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (11)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2008 · fourth_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, H.R. 6331, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219, S. 3101: provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. H. Res. 1368, to suspend section 803 of the Medicare Modernization Act of 2003 (known as the Medicare trigger") for the remainder of the 110th Congress. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: interim final rule to implement Section 6052 of the Deficit Medicaid/Targeted Case Management (continued). Reduction Act.
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, H.R. 6331, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219, S. 3101: Medicare/General (continued). provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. H. Res. 1368, to suspend section 803 of the Medicare Modernization Act of 2003 (known as the Medicare trigger") for the remainder of the 110th Congress. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicare/Identity Theft Prevention. H.R. 6600, provisions related to removal of Social Security numbers from Medicare cards. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: interim final rule to implement Section 6052 of the Deficit Reduction Act.
2008 · second_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, H.R. 6331, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219, S. 3101: provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: Interim final rule to implement Section 6052 of the Deficit Reduction Act.
2008 · first_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219: provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, Medicare Secondary Payer clarification, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: interim final rule to implement Section 6052 of the Deficit Reduction Act.
2008 · fourth_quarter · Pharmacy
HR 1038/HR 1956/HR5629--creation of a regulatory pathway for generic biologics S 1088/S 28/S 316/HR 1902--issues related to bringing generics to market in a timely fashion S. 596/S 980/HR 6353--internet pharmacy regulations HR 5839--issues relating to prescription drug pedigree/drug safety
Client expense: $430,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Legal Services Corporation, Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Client expense: $280,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $480,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
Generic Drugs and Biologics H.R.1038/S.623: Access to Life Saving Medicine Act S.1695: Biologics Price Competition and Innovation Act S.1088: Lower Priced Drugs Act; H.R.5629: The Pathway for Biosimilars Act State generic substitution law carve outs Chronic Disease Management
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, H.R. 6331, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219, S. 3101: provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. H. Res. 1368, to suspend section 803 of the Medicare Modernization Act of 2003 (known as the Medicare trigger") for the remainder of the 110th Congress. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: interim final rule to implement Section 6052 of the Deficit Medicaid/Targeted Case Management (continued). Reduction Act.
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
Generic Biologics, including but not limited to: S.623, S.1505, S.1695, H.R.1038, H.R.1956, and H.R.5629 Prescription Drug Safety Food and Drug Administration Act of 2007 (H.R.3580): any parts relating to access to generic drugs and the impact and marketing of prescription drugs Citizen Petitions, including but not limited to: S.25 and S.1088 Counterfeit Drugs/Import Safety/Pedigree including but not limited to: S.3409 and H.R.5839 Electronic Prescribing Authorized Generics including but not limited to: S.2408 and H.R.4296 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs
Client expense: $539,634 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2008 · third_quarter · Health Issues
Genetic nondiscrimination: H.R.493/S.358: Genetic Information Nondiscrimination Act Generic Drugs and Biologics H.R.1038/S.623: Access to Life Saving Medicine Act S.1695: Biologics Price Competition and Innovation Act S.1088: Lower Priced Drugs Act; H.R.5629: The Pathway for Biosimilars Act State generic substitution low carve outs
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · second_quarter · Health Issues
Genetic nondiscrimination: H.R.493/S.358: Genetic Information Nondiscrimination Act Generic Drugs and Biologics H.R.1038/S.623: Access to Life Saving Medicine Act S.1695: Biologics Price Competition and Innovation Act S.1088: Lower Priced Drugs Act; H.R.5629: The Pathway for Biosimilars Act State generic substitution low carve outs
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · third_quarter · Health Issues
Generic Biologics H.R.1038/S.623: Access to Life-Saving Medicine Act S.1695: Biologics Price Competition and Innovation Act of 2007 H.R.5629: Pathway for Biosimiliars Act Citizen Petitions S.1088: Lower PRICED Drugs Act Drug Safety S.484: Enhancing Drug Safety and Innovation Act of 2007 H.R.5839: Safeguarding America's Pharmaceuticals Act of 2008 H.R. 3610: Food and Drug Import Safety Act of 2007 S. 3409: Drug and Device Accountability Act of 2008 Authorized Generics H.R.806: To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs Generic substitution state come-out laws
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · third_quarter · Pharmacy
Generic Biologics, including but not limited to: S.623, S.1505, S.1695, H.R.1038, H.R.1956, and H.R.5629 Prescription Drug Safety Food and Drug Administration Act of 2007 (H.R.3580): any parts relating to access to generic drugs and the impact and marketing of prescription drugs Citizen Petitions, including but not limited to: S.25 and S.1088 Counterfeit Drugs/Import Safety/Pedigree including but not limited to: S.3409 and H.R.5839 Electronic Prescribing (E-Prescribing) Authorized Generics including but not limited to: S.2408 and H.R.4296 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs
Client expense: $506,976 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2008 · third_quarter · Pharmacy
HR 1038/HR 1956/S 1695/HR 5629--creation of a regulatory pathway for generic biologics S 1088/S 28/S 316/HR 1902--Issues related to bringing generics to market in a timely fashion S. 596/S. 980/HR 6353--internet pharmacy regulations HR 5839--issues relating to prescription drug pedigree/drug safety
Client expense: $240,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
2008 · third_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, H.R. 6331, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219, S. 3101: Medicare/General (continued). provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. H. Res. 1368, to suspend section 803 of the Medicare Modernization Act of 2003 (known as the Medicare trigger") for the remainder of the 110th Congress. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicare/Identity Theft Prevention. H.R. 6600, provisions related to removal of Social Security numbers from Medicare cards. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: interim final rule to implement Section 6052 of the Deficit Reduction Act.
Client expense: $280,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Pharmacy
Items relating to the implementation of PL 110-85, the FDA reauthorization Act of 2007 HR 1038/HR 1956/S. 1695/HR 5629--regulatory pathway for generic biologics S. 1088/S. 28/S. 316/HR 1902--Issues related to bringing generics to market in a timely fashion S. 596/S. 980--internet pharmacy regulations Issues relating to the DOL's proposed disclosure of compensation for service fee providers under ERISA
Client expense: $210,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE, White House Office
2008 · second_quarter · Pharmacy
Generic Biologics, including but not limited to: S.623, S.1505, S.1695, H.R.1038, H.R.1956, and H.R.5629 Prescription Drug Safety Food and Drug Administration Amendments Act of 2007 (H.R.3580): any parts relating to access to generic drugs and the impact and marketing of prescription drugs Citizen Petitions, including but not limited to: S.25 and S.1088 Counterfeit Drugs/Import Safety/Pedigree Electronic Prescribing (E-Prescribing) Authorized Generics including but not limited to: S.2408 and H.R.4296 Prescription Drug Importation/Re-Importation Any other matters that relates to access to generic drugs
Client expense: $459,139 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2008 · second_quarter · Health Issues
Generic Drugs and Biologics H.R.1038/S.623: Access to Life Saving Medicine Act S.1695: Biologics Price Competition and Innovation Act S.1088: Lower Priced Drugs Act H.R.5629: The Pathway for Biosimilars Act
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · second_quarter · Health Issues
Generic Biologics S.623: Access to Life-Saving Medicine Act S.1695: Biologics Price Competition and Innovation Act of 2007 H.R.5629: Pathway for Biosimiliars Act Citizen Petitions S.1088: Lower PRICED Drugs Act Drug Safety S.484: Enhancing Drug Safety and Innovation Act of 2007 H.R.5839: Safeguarding America's Pharmaceuticals Act of 2008 Authorized Generics H.R.806: To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · second_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, H.R. 6331, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219, S. 3101: provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: Interim final rule to implement Section 6052 of the Deficit Reduction Act.
Client expense: $440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Health Issues
Generic Biologics S.623: Access to Life-Saving Medicine Act S.1695: Biologics Price Competition and Innovation Act of 2007 H.R. 5629: Pathway for Biosimilars Act Citizen Petitions S. 1088: Lower PRICED Drugs Act Drug Safety S. 484: Enhancing Drug Safety and Innovation Act of 2007 H.R. 3610: Food and Drug Import Safety Act of 2007 Authorized Generics H.R. 806: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs User fees
Client expense: Not reported · Firm income: $60,000
2008 · first_quarter · Pharmacy
Generic Biologics, including but not limited to: S.623, S.1505, S.1695, H.R.1038, H.R.1956, and H.R.5629 Prescription Drug Safety Food and Drug Administration Amendments Act of 2007 (H.R.3580): any parts relating to access to generic drugs and the impact and marketing of prescription drugs Citizen Petitions, including but not limited to: S.25 and S.1088 Counterfeit Drugs/Import Safety/Pedigree Authorized Generics including but not limited to: S.438 and H.R.806 Electronic Prescribing (E-Prescribing), including but not limited to: S.2408 and H.R.4296 Prescription Drug Importation/Re-Importation Any other matter that relates to access to generic drugs
Client expense: $434,495 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2008 · first_quarter · Pharmacy
S. 316, the Preserve Access to Affordable Generics Act HR 1902, the Protecting Consumer Access to Generic Drugs Act HR 1432, the Preserve Access to Affordable Generics Act HR 1038, the Access to Life Savings Medicine Act S. 623, the Access to Life Savings Medicine Act S. 1695, the Biologics Price Competition and Innovation Act S. 1088, Lower Priced Drugs Act HR 3610, the Food and Drug Import Safety Act, Section 4, User Fees Regarding Drug Safety Pharmaceutical pedigree/track and trace issues
Client expense: $130,000 · Firm income: Not reported
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Health Issues
Health Information Technology S.1693: Wired for Health Care Quality Act Innappropriate use of human growth hormone Genetic non-discrimination H.R.493/S.358: Genetic Information Nondiscrimination Act Generic Drugs and Biologics H.R.1038/S.623: Access to Life Saving Medicine Act S.1695: Biologics Price Competiton and Innovation Act S.1088: Lower Priced Drugs Act H.R. 5629: The Pathway for Biosimilars Act
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · first_quarter · Pharmacy
Items related to the implementation of PL 110-85, the FDA reauthorization act of 2007 HR 1038/HR 1956/S 1695/ HR 5629--Regulatory pathway for generic biologics S 1088/S 28/S 316/HR 1902--Issues related to bring generics to market in a timely fashion S 596/S 980 -- Internet pharmacies Issues relating to the DOL's proposed disclosure of compensation for service fee providers under ERISA
Client expense: $180,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE, White House Office
2008 · first_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219: provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, Medicare Secondary Payer clarification, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: interim final rule to implement Section 6052 of the Deficit Reduction Act.
Client expense: $480,000 · Firm income: Not reported
2007 · year_end · Medicare/Medicaid
Medicare. 1) H.R. 4, H.R. 118, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. 2) H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, S. 137, S. 250, S.450, S. 706, S. 1887, S. 2115, S. 2219, S. 2499, S.Amdt. 508: provisions relating to the late enrollment penalty, physician reimbursement rates, creation of a Medicare operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repeal of cost containment provisions, Medicare Advantage payments, the Medicare Advantage stabilization fund and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalization of asset test limits, the reduction of the benefit gap and guaranteeing drug benefits. 3) H.R. 2945: provisions to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. 4) S. 242, H.R. 380, S.Amdt. 1010: pertaining to the importation of prescription drugs. 5) H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under the Medicare Program. 6) S. 1340, H.R. 2244: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. 7) S. 316, S. 1088, H.R. 1432, H.R. 1902: pertaining to market exclusivity for generic drugs. 8) S. 1102, S. 1103, S. 1107, S. 1108, S. 2101, H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, H.R. 3668: provisions to improve benefits for low-income beneficiaries under Medicare Parts B and D. 9) S. 1082: amendments pertaining to citizen petitions to the Federal Drug Administration relating to generic drugs and to importation of prescription drugs under the Medicare program. 10) H.R. 2591: limiting the penalty for late enrollment under Medicare Part B. 11) H.R. 2307, H.R. 4790, S. 1883: provisions regarding the marketing of Medicare Advantage and Medicare Part D plans. 12) H.R. 749: establishing health care vouchers for seniors. 13) S. 173, S. 1019, H.R. 2639: provisions pertaining to Medicare Savings Accounts. 14) S. 464, S. 465, S. 466: provisions pertaining to advance directives and end-of-life planning. 15) S.Amdt. 472: provisions pertaining to means-testing of Medicare Part D. 16) S.Amdt. 525: pertaining to across-the-board cuts to Medicare providers. 17) S. 543, H.R. 1459: rules pertaining to Inpatient Rehabilitation Facilities. 18) Pertaining to Congressional efforts petitioning the Center for Medicare and Medicaid Services to create a public nursing home watch list of repeat offenders on surveys (no legislation).
Client expense: $4,440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · mid_year · Medicare/Medicaid
Medicare. 1) H.R. 4, H.R. 118, S. 3, S. 273: pertaining to the negotiation of prescription drug prices under Medicare Part D. 2) H.R. 205, H.R. 1218, H.R. 1310, H.R. 1521, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, S. 250, S. 706: provisions relating to the late enrollment penalty, creating a Medicare operated prescription drug plan, prescription drug price negotiations, repealing cost containment provisions, Medicare Advantage stabilization fund and comparative cost adjustment demonstration projects under the Medicare Modernization Act (P.L. 108-173), liberalizing asset test limits, reducing the benefit gap and guaranteeing prescription drug benefits. 3) H.R. 2945: providing beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. 4) S. 242, H.R. 380: pertaining to the importation of prescription drugs. 5) H.R. 1571, H.R. 1663, S. 1715: eliminating discriminatory copayment rates for outpatient psychiatric services under the Medicare Program. 6) S. 1340, H.R. 2244: to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. 7) S. 316, S. 1088, H.R. 1432, H.R. 1902: pertaining to market exclusivity for generic drugs. 8) S. 1102, S. 1103, S. 1107, S. 1108, H.R. 470, H.R. 932, H.R. 1536, H.R. 2058: improving prescription drug benefits for low-income beneficiaries under Medicare Part D. 9) S. 1082: amendments pertaining to citizen petitions to the Federal Drug Administration relating to generic drugs and to importation of prescription drugs under the Medicare program. 10) H.R. 2591: limiting the penalty for late enrollment under Medicare Part B. 11) H.R. 2009: repealing the Medicare cost containment provisions of the Medicare Modernization Act (P.L. 108-173). 12) H.R. 2307: protecting seniors from abusive marketing scams in Medicare Advantage. 13) H.R. 749: establishing health care vouchers for seniors. 14) S. 173, S. 1019, H.R. 2639: pertaining to Medicare Savings Accounts. 15) S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning.
Client expense: $4,860,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Pharmacy
S. 316, the Preserve Access to Affordable Pharmaceuticals Act HR 1902, Protecting Consumer Access to Generic Drugs Act HR 1038, Access to Life Savings Medicine Act S. 623, Access to Life Savings Medicine Act S 1695, Biologics Price Competition and Innovation Act S 1088, Lower Priced Drugs Act HR 3580, FDA Amendment Act of 2007 Abbreviated New Drug Application No. 76-396 for calcitonin salmon nasal spray HR 3610, the Food and Drug Import Safety Act, Section 4, User Fees Regarding Drug Safety
Client expense: $250,000 · Firm income: Not reported
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE, UNDETERMINED
2007 · year_end · Health Issues
S.25, Citizen Petition Fairness and Accuracy Act of 2007 S.623 and H.R. 1038, Access to Life Saving Medicine Act S.438 and H.R. 806, Fair Prescription Drug Competition Act S.1082, FDA Revitalization Act S.1088, Lower Priced Drugs Act S.1505, Affordable Biologics Price Competition and Innovation Act S.1695, Patent Protection and Innovative Biologic Medicines Act H.R. 2900, Food and Drug Administration Amendments of 2007 H.R.1432 and S.316, Preserve Access to Affordable Generics Act H.R. 1908 and S.1145, Patent Reform Act of 2007 H.R. 1902, Protecting Consumer Access to Generic Drugs Act
Client expense: $1,040,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, UNDETERMINED, White House Office
2007 · year_end · Pharmacy
Biologics S.623/H.R.1038: Access to Life Saving Medicine Act Office of Generic Drugs Appropriations Bills S.1859/H.R.3161: Agriculture, Rural Development, Food and Drug Administration and Related Agencies Act, 2008 S.1082/H.R.3580: Food and Drug Administration Revitilzation Act of 2007 S.1088: Lower Priced Drugs Act
Client expense: Not reported · Firm income: $100,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, UNDETERMINED, White House Office
2007 · year_end · Pharmacy
Appropriations Bills S.1859/H.R.3161: Agriculture, Rural Development, Food and Drug Administration and Related Agencies Act, 2008 S.1082/H.R.3580: Food and Drug Administration Revitilzation Act of 2007 S.1088: Lower Priced Drugs Act Biologics S.623/H.R.1038: Access to Life Saving Medicine Act Office of Generic Drugs
Client expense: Not reported · Firm income: $100,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2007 · year_end · Pharmacy
S. 25 Citizen Petition Fairness and Accuracy Act of 2007, S.623/HR 1038 Access to Life-Saving Medicine Act, S. 438/HR 806 Fair Prescription Drug Competition Act, S.1082 Food and Drug Administration Revitalization Act, S. 1088 Lower PRICED Drugs Act, S.1505 Affordable Biologics for Consumers Act, S. 1695 Biologics Price Competition and Innovation Act of 2007, H.R. 1956, H.R. 2900, H.R. 3140, H.R. 2606, HR 3580, HR 3610
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2007 · year_end · Health Issues
S.242: Phamaceutical Market Access and Drug Safety Act Genetic non-discrimination H.R.493/S.358: Genetic Information Nondiscrimination Act Generic Drugs and Biologics H.R.1038/S.623: Access to Life Saving Medicine Act S.1695: Biologics Price Competiton and Innovation Act S.1088: Lower Priced Drugs Act Health Information Technology S.1693: Wired for Health Care Quality Act Reimportation S.251: Pharmaceutical Market Access Act
Client expense: Not reported · Firm income: $100,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2007 · year_end · Health Issues
S. 1088: Lower PRICED Drugs Act Drug Safety S. 1082: Food and Drug Administration Revitalization Act S. 484: Enhancing Drug Safety and Innovation Act of 2007 H.R. 3610: Food and Drug Import Safety Act of 2007 Pediatric Exclusivity S. 1082: Food and Drug Administration Revitalization Act H.R. 2900: Food and Drug Administration Amendments Act of 2007 Authorized Generics H.R. 806: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs User fees S. 1145: Patent Reform Act of 2007 Appropriations Generic Biologics S.623: Access to Life-Saving Medicine Act S.1695: Biologics Price Competition and Innovation Act of 2007 Citizen Positions
Client expense: Not reported · Firm income: $120,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2007 · year_end · Pharmacy
Generic Biologics - S.623, S.1695, H.R.1038, and H.R.1956 Pediatric Exclusivity - S.1082, H.R.2900, and H.R.3580 Drug Safety - S.484, S.1082, H.R.3580 Authorized Generics - S.438 and H.R.806 Citizen Petitions - S.1088, S.25, and H.R.3580 Import Safety - H.R.3610 Counterfeit Drugs - S.242, S.1082, H.R.780, H.R.2710, H.R.3580, and H.R.3610
Client expense: $398,128 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2007 · year_end · Pharmacy
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956/S. 1695--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Client expense: $490,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2007 · year_end · Medicare/Medicaid
H.R. 3061, H.R. 3162, H.R. 3932, S. 137, S. 250, S.450, S. 706, S. 1887, S. 2115, S. 2219, S. 2499, S.Amdt. 508: provisions relating to the late enrollment penalty, physician reimbursement rates, creation of a Medicare operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repeal of cost containment provisions, Medicare Advantage payments, the Medicare Advantage stabilization fund and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalization of asset test limits, the reduction of the benefit gap and guaranteeing drug benefits. 3) H.R. 2945: provisions to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. 4) S. 242, H.R. 380, S.Amdt. 1010: pertaining to the importation of prescription drugs. 5) H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under the Medicare Program. 6) S. 1340, H.R. 2244: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. 7) S. 316, S. 1088, H.R. 1432, H.R. 1902: pertaining to market exclusivity for generic drugs. 8) S. 1102, S. 1103, S. 1107, S. 1108, S. 2101, H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, H.R. 3668: provisions to improve benefits for low-income beneficiaries under Medicare Parts B and D. 9) S. 1082: amendments pertaining to citizen petitions to the Federal Drug Administration relating to generic drugs and to importation of prescription drugs under the Medicare program. 10) H.R. 2591: limiting the penalty for late enrollment under Medicare Part B. 11) H.R. 2307, H.R. 4790, S. 1883: provisions regarding the marketing of Medicare Advantage and Medicare Part D plans. 12) H.R. 749: establishing health care vouchers for seniors. 13) S. 173, S. 1019, H.R. 2639: provisions pertaining to Medicare Savings Accounts. 14) S. 464, S. 465, S. 466: provisions pertaining to advance directives and end-of-life planning. 15) S.Amdt. 472: provisions pertaining to means-testing of Medicare Part D. 16) S.Amdt. 525: pertaining to across-the-board cuts to Medicare providers. 17) S. 543, H.R. 1459: rules pertaining to Inpatient Rehabilitation Facilities. 18) Pertaining to Congressional efforts petitioning the Center for Medicare and Medicaid Services to create a public nursing home “watch list” of repeat offenders on surveys (no legislation). Medicare. 1) H.R. 4, H.R. 118, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. 2) H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025,
Client expense: $4,440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
2007 · mid_year · Pharmacy
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Client expense: $490,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2007 · mid_year · Pharmacy
H.R. 1038 - Access to Life-Saving Medicine Act S. 1082 - Food and Drug Administration Revitalization Act S. 1088 - Lower PRICED Drugs Act S. 1505 - Affordable Biologics for Consumers Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 1956 - The Patient Protection and Innovative Biologic Medicines Act H.R. 2900 - Food and Drug Administration Amendments Act of 2007 H.R. 3140 - Saving Our Community Pharmacy Act of 2007 H.R. 2606 - 340B Program Improvement and Integrity Act of 2007 S. 25 - Citizen Petition Fairness and Accuracy Act of 2007 S. 623 - Access to Life-Saving Medicine Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act]
Client expense: $1,100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2007 · mid_year · Pharmacy
Generic Biologics - S.623, S.1695, H.R. 1038, and H.R. 1956 Pediatric Exclusivity - S.1082 and H.R. 2900 Drug Safety - S.484 and S.1082 Authorized Generics - S.438 and H.R. 806 Citizen Petitions - S.1088 and S.25 Counterfeit Drugs - S.242, S.1082, H.R. 780 and H.R.2710
Client expense: $420,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2007 · mid_year · Health Issues
S. 558, Mental Health Parity Act of 2007 S. 667, Education Begins at Home Act S. 1088, Lower PRICED Drugs Act S. 1169, State-Based Health Care Reform ACt S. 1408, Health Information Technology Act of 2007 H.R. 15, National Health Insurance Act H.R. 1367 and 1424, Paul Wellstone Mental Health and Addiction Equity Act H.R. 1368, Personalized Health Information Act of 2007 H.R. 1841, AmeriCare Health Care Act of 2007 H.R. 2351, HealthCARE Act of 2007 H.R. 3014, Health Equity and Accountability Act of 2007 Supported all provisions unless otherwise indicated S. 586, H.R. 1968, Community Health Workers Act of 2007 S. 1218, H.R. 2034, Medicare for All Act S. 334, Healthy Americans Act
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · mid_year · Pharmacy
S 1695, Biologics Price Competition and Innovation Act S. 1088, Lower Priced Drugs Act S. 1082, the Food and Drug Administration Revitalization Act, including Title VIII, Importation of Prescription Drugs (Section 6, Wholsale Distribution of Drugs) S AMDT 1011 on Citizen Petitions HR 2900 Food and Drug Administration Amendments of 2007, including provisions concerning the citizen petition process Reauthorization of Pediatric Exclusivity program in House and Senate Abbreviated New Drug Application No. 76-396 for calcitonin-salmon nasal spray S. 316, the Preserve Access to Affordable Pharamceuticals Act HR 1902, Protecting Consumer Access to Generic Drugs Act HR 1038, Access to Life Savings Medicine Act S 623, Access to Life Savings Medicine Act
Client expense: $118,300 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2007 · mid_year · Health Issues
ERISA preemption issues Medicare Availability to Early Retirees Medicare Prescription Drug Issues Medicare Quality Enhancement Act (S 1544, S 1693) Mental Health Parity legislation (S 558, HR 1424) Office of Generic Drug Funding (HR 3161, S 1859) The Lower Priced Drugs Act/Citizen Petition/Pediatric Exclusivity Issues (S 1088, HR 2900, S 1082) Biogenerics legislation (S 623, HR 1038, S 1695, S 1505, HR 1956, S 1082, HR 2900) Comparative Effectiveness Research (HR 3043, S 1710, HR 2184) Genetics Information NonDiscrimination Act (S 358, HR 493) Health Information Technology (S 1693, S 1408)
Client expense: $6,200,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Economic Council (NEC), Natl Highway Traffic Safety Administration (NHTSA), Natl Security Council (NSC), Natl Transportation Safety Board (NTSB), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Overseas Private Investment Corp (OPIC), SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2007 · mid_year · Pharmacy
S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing
Client expense: $390,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2007 · mid_year · Pharmacy
H.R. 1038 Access to Life-Saving Medicine Act - all provisions S.1082 Food and Drug Administration Revitalization Act - all provisions S. 1088 Lower PRICED Drugs Act- all provisions S.1505 Affordable Biologics for Consumers Act - all provisions S. 1695 Biologics Price Competition and Innovation Act of 2007- all provisions H.R. 1956 The Patient Protection and Innovative Biologic Medicines Act - all provisions H.R. 2900 Food and Drug Administration Amendments Act of 2007 - all provisions S. 25, Citizen Petition Fairness and Accuracy Act of 2007 - all provisions S.623, Access to Life-Saving Medicine Act - all provisions S. 438, Fair Prescription Drug Competition Act - all provisions H.R. 806, Fair Prescription Drug Competition Act - all provisions
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2007 · mid_year · Medicare/Medicaid
to the late enrollment penalty, creating a Medicare operated prescription drug plan, prescription drug price negotiations, repealing cost containment provisions, Medicare Advantage stabilization fund and comparative cost adjustment demonstration projects under the Medicare Modernization Act (P.L. 108-173), liberalizing asset test limits, reducing the benefit gap and guaranteeing prescription drug benefits. 3) H.R. 2945: providing beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. 4) S. 242, H.R. 380: pertaining to the importation of prescription drugs. 5) H.R. 1571, H.R. 1663, S. 1715: eliminating discriminatory copayment rates for outpatient psychiatric services under the Medicare Program. 6) S. 1340, H.R. 2244: to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. 7) S. 316, S. 1088, H.R. 1432, H.R. 1902: pertaining to market exclusivity for generic drugs. 8) S. 1102, S. 1103, S. 1107, S. 1108, H.R. 470, H.R. 932, H.R. 1536, H.R. 2058: improving prescription drug benefits for low-income beneficiaries under Medicare Part D. 9) S. 1082: amendments pertaining to citizen petitions to the Federal Drug Administration relating to generic drugs and to importation of prescription drugs under the Medicare program. 10) H.R. 2591: limiting the penalty for late enrollment under Medicare Part B. 11) H.R. 2009: repealing the Medicare cost containment provisions of the Medicare Modernization Act (P.L. 108-173). 12) H.R. 2307: protecting seniors from abusive marketing scams in Medicare Advantage. 13) H.R. 749: establishing health care vouchers for seniors. 14) S. 173, S. 1019, H.R. 2639: pertaining to Medicare Savings Accounts. 15) S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare. 1) H.R. 4, H.R. 118, S. 3, S. 273: pertaining to the negotiation of prescription drug prices under Medicare Part D. 2) H.R. 205, H.R. 1218, H.R. 1310, H.R. 1521, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, S. 250, S. 706: provisions relating
Client expense: $4,860,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · mid_year · Pharmacy
45. S.1932, the Deficit Reduction Act (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 46. S. 1548 - Department of Defense Authorization Act for Fiscal Year 2008 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 47. H.R. 1585 - National Defense Authorization Act for Fiscal Year 2008 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 1. H.R. 4241, the Deficit Reduction Act of 2005 2. S. 1932, the Deficit Reduction Act of 2005 3. S. 1695, the Biologics Price Competition and Innovation Act of 2007 4. H.R.1038, Access to Life-Saving Medicine Act 5. S. 623, the Access to Life-Saving Medicine Act 6. H.R. 2900, the Food and Drug Administration Amendments of 2007 7. S. 1082, Food and Drug Administration Revitalization Act 8. H.R.1585, the National Defense Authorization Act 9. S. 1548 - Department of Defense Authorization Act for Fiscal Year 2008 10. S. 1693, the Wired for Health Care Quality Act of 2007 11. H.R. 1952, the National Health Information Incentive Act 12. H.R. 2747, the Methamphetamine Production Prevention Act of 2007 13. S. 1276, the Methamphetamine Production Prevention Act of 2007 14. H.R.1591, the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007 15. S. 3, the Medicare Fair Prescription Drug Price Act of 2007 16. S. 1088, the Lower Prices Reduced With Increased Competition and Efficient Development of Drugs Act 17. H.R. 1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 18. S.242, the Pharmaceutical Market Access and Drug Safety Act of 2007 19. H.R. 800, the Employee Free Choice Act of 2007 20. S. 596, the Safe Internet Pharmacy Act of 2007 21. H.R.976, Small Business Tax Relief Act of 2007 22. H.R. 970, the Dextromethorphan Distribution Act of 2007 23. H.R. 971, the Community Pharmacy Fairness Act of 2007 24. S. 885, the Community Pharmacy Fairness Act of 2007 25. H.R. 2, the Fair Minimum Wage Act of 2007 26. S. 2, the Fair Minimum Wage Act of 2007 27. S. 484, the Enhancing Drug Safety and Innovation Act of 2007 28. H.R. 4, the Medicare Prescription Drug Price Negotiation Act of 2007 29. H.R.380, the Pharmaceutical Market Access and Drug Safety Act of 2007 30. H.R.3090, Patient and Pharmacy Protection Act of 2007 31. S.3, the Medicare Prescription Drug Price Negotiation Act of 2007 32. S.251, the Pharmaceutical Market Access Act of 2007 33. S. 604, the Military Health Care Protection Act 34. S. 980, Online Pharmacy Consumer Protection Act of 2007 35. S.1224, Children's Health Insurance Program (CHIP) Reauthorization Act of 2007 36. H.R.1845, the Medicare Durable Medical Equipment Access Act of 2007 37. H.R.1902, the Protecting Consumer Access to Generic Drugs Act of 2007 38. H.R. 2206, the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007 39. H.R. 2596, the Access to Birth Control Act 40. H.R.2716, the Reducing Fraudulent and Imitation Drugs Act of 2007 41. H.R.3043, the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008 42. S. 1710, the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008 43. H.R.3161, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008 44. H.R. 5182 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) See addendum
Client expense: $340,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, White House Office